Cayud Ong, Mckinley A.

HRN: 23-43-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2023
CEFUROXIME 1.5GM (VIAL)
09/15/2023
09/22/2023
IV
150
Q8
Pcap C
Waiting Final Action 
09/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/15/2023
09/22/2023
IV
75
OD
Pcap
Waiting Final Action 
01/07/2025
CEFUROXIME 750MG (VIAL)
01/07/2025
01/14/2025
IV
350 Mg
Q8h
PCAP C
Waiting Final Action 
01/10/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/10/2025
01/16/2025
IV
75mg
Q12
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: